Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H31N5O3.ClH |
| Molecular Weight | 437.963 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.O[C@@H]1C(=O)N(CCCCN2CCN(CC2)C3=NC=CC=N3)C(=O)CC14CCCC4
InChI
InChIKey=QQVBLEXAVSAUDT-GMUIIQOCSA-N
InChI=1S/C21H31N5O3.ClH/c27-17-16-21(6-1-2-7-21)18(28)19(29)26(17)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20;/h5,8-9,18,28H,1-4,6-7,10-16H2;1H/t18-;/m1./s1
BMS-442606 is an S-enantiomer of 6-hydroxybuspirone and is a 5-HT1A partial agonist. BMS-442606 has advantage of being cleared more slowly from blood compared to the R-enantiomer, but R form showed higher affinity and selectivity for the 5HT1A receptor compared to the S-isomer. Because both isomers together with racemic form were well tolerated and was not found any advantage of one of the enantiomers of over the racemic form. Finally, racemic form was chosen for further clinical development.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ZF7MCG33V0
Created by
admin on Fri Dec 15 15:36:24 GMT 2023 , Edited by admin on Fri Dec 15 15:36:24 GMT 2023
|
PRIMARY | |||
|
91826494
Created by
admin on Fri Dec 15 15:36:24 GMT 2023 , Edited by admin on Fri Dec 15 15:36:24 GMT 2023
|
PRIMARY | |||
|
2108875-94-9
Created by
admin on Fri Dec 15 15:36:24 GMT 2023 , Edited by admin on Fri Dec 15 15:36:24 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
